Embryonal Tumor With Multilayered Rosettes
Public ClinicalTrials.gov record NCT06861244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PNOC031: Protocol for Embryonal Tumor With Multilayered Rosettes (ETMR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, comprehensive, iterative investigation of evaluating the use of induction chemotherapy, high-dose chemotherapy, and focal radiation therapy in children with newly diagnosed Embryonal Tumor With Multilayered Rosettes (ETMR).
Study identification
- NCT ID
- NCT06861244
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- Radiotherapy (RT) Radiation
- Chemotherapy Drug, Cancer - Physician's Choice Drug
- Non-Investigational Surgical Resection Procedure
- Temozolomide Drug
- Tumor Tissue Sample Procedure
- Blood Sample Procedure
- Cerebrospinal Fluid (CSF) Sample Procedure
Radiation · Drug · Procedure
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 5, 2025
- Primary completion
- Sep 29, 2030
- Completion
- Mar 30, 2032
- Last update posted
- Jun 28, 2026
2025 – 2032
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | Recruiting |
| University of California, San Francisco | San Francisco | California | 94143 | Recruiting |
| Riley Hospital for Children at Indiana University Health | Indianapolis | Indiana | 46202 | Recruiting |
| Johns Hopkins University | Baltimore | Maryland | 21218 | Recruiting |
| Washington University in St. Louis | St Louis | Missouri | 63130 | Recruiting |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | Recruiting |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | Recruiting |
| University of Utah | Salt Lake City | Utah | 84113 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06861244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06861244 live on ClinicalTrials.gov.